191 related articles for article (PubMed ID: 1705994)
21. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.
Choi WS; Collignon C; Thiriart C; Burns DP; Stott EJ; Kent KA; Desrosiers RC
J Virol; 1994 Sep; 68(9):5395-402. PubMed ID: 7520089
[TBL] [Abstract][Full Text] [Related]
22. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.
Burns DP; Desrosiers RC
Curr Top Microbiol Immunol; 1994; 188():185-219. PubMed ID: 7523031
[TBL] [Abstract][Full Text] [Related]
23. Neutralising epitopes of simian immunodeficiency virus envelope glycoprotein.
Kent KA
J Med Primatol; 1995 May; 24(3):145-9. PubMed ID: 8751054
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.
Martinez-Navio JM; Desrosiers RC
J Virol; 2012 Dec; 86(23):12484-93. PubMed ID: 22993152
[TBL] [Abstract][Full Text] [Related]
25. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
26. Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection.
Chuang LF; Blackbourn DJ; Chuang AJ; Killam KF; Liu X; Li Y; Kung HF; Chuang RY
Cell Mol Biol Res; 1994; 40(7-8):661-9. PubMed ID: 7787884
[TBL] [Abstract][Full Text] [Related]
27. Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.
Yen PJ; Herschhorn A; Haim H; Salas I; Gu C; Sodroski J; Gabuzda D
J Virol; 2014 May; 88(9):5014-28. PubMed ID: 24554659
[TBL] [Abstract][Full Text] [Related]
28. Neutralization of SIVmac239/17E in lymphocyte cultures involves virus strain-specific linear and conformational epitopes encoded by different regions of the env gene including the "V3" domain.
Wu Z; Qian G; Zhen QL; Narayan O; Stephens EB
Virology; 1996 Aug; 222(1):184-92. PubMed ID: 8806498
[TBL] [Abstract][Full Text] [Related]
29. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
Morrison HG; Kirchhoff F; Desrosiers RC
Virology; 1993 Jul; 195(1):167-74. PubMed ID: 8317093
[TBL] [Abstract][Full Text] [Related]
31. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
[TBL] [Abstract][Full Text] [Related]
32. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
[TBL] [Abstract][Full Text] [Related]
33. Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy.
Mills KH; Page M; Kitchin P; Chan L; Jones W; Silvera P; Corcoran T; Flanagan B; Ling C; Thiriart C
J Med Primatol; 1993; 22(2-3):104-9. PubMed ID: 8411102
[TBL] [Abstract][Full Text] [Related]
34. Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys.
von Gegerfelt A; Nilsson C; Putkonen P; Broliden K
Vaccine; 1994 Oct; 12(13):1203-8. PubMed ID: 7839725
[TBL] [Abstract][Full Text] [Related]
35. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.
Yuste E; Sanford HB; Carmody J; Bixby J; Little S; Zwick MB; Greenough T; Burton DR; Richman DD; Desrosiers RC; Johnson WE
J Virol; 2006 Mar; 80(6):3030-41. PubMed ID: 16501112
[TBL] [Abstract][Full Text] [Related]
36. Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.
Faith SA; Wu Y; Kuhrt D; Steckbeck JD; Craigo JK; Clements JE; Cole KS
Virology; 2010 Apr; 400(1):86-92. PubMed ID: 20153009
[TBL] [Abstract][Full Text] [Related]
37. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
Meyer D; Anderson DE; Gardner MB; Torres JV
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
[TBL] [Abstract][Full Text] [Related]
38. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
[TBL] [Abstract][Full Text] [Related]
39. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.
Cheng-Mayer C; Brown A; Harouse J; Luciw PA; Mayer AJ
J Virol; 1999 Jul; 73(7):5294-300. PubMed ID: 10364275
[TBL] [Abstract][Full Text] [Related]
40. Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2.
Sutjipto S; Kodama T; Yee J; Gettie A; Jennings M; Desrosiers RC; Marx PA
J Gen Virol; 1990 Jan; 71 ( Pt 1)():247-9. PubMed ID: 1689369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
